A global pharma firm faced the challenge of monitoring the surge of COVID-19 literature. Partnering with IQVIA, they applied a blend of NLP, ontologies, and Generative AI (GPT) to extract >150 data points across 25 categories from 130+ studies. The process was 2.5–3x faster than manual methods, scalable, and 24/7. Data was curated and summarized by experts, then published on open-access sites for vaccines and antivirals. This streamlined real-world evidence access for researchers, enabling faster insights into treatment effectiveness and emerging conditions like long COVID.

Join for free to read